Sodium-glucose cotransporter 2 inhibitors as the first universal treatment of chronic kidney disease Usama Abdel Azim Sharaf El Din; Mona Mansour Salem; Dina Ossama Abdulazim;

Mineralcorticoid receptor blockers in chronic kidney disease Sara Erraez; Manuel López-Mesa; Pablo Gómez-Fernández;

Projection of the clinical and economic burden of chronic kidney disease between 2022 and 2027 in Spain: Results of the Inside CKD project Juan F. Navarro González; Alberto Ortiz; Ana Cebrián Cuenca; Marta Moreno Barón; Lluís Segú; Belén Pimentel; Unai Aranda; Blanca Lopez-Chicheri; Margarita Capel; Elisenda Pomares Mallol; Christian Caudron; Juan José García Sánchez; Roberto Alcázar Arroyo;